THE 2003 CALHOUN-ROONEY LITERATURE REVIEW: Lumley Study, 1993 and 98; Bavarian Study, 1998; Danish Study, 1999 Reference: Calhoun, B, Rooney, B; Induced Abortion and Risk of Later Premature Birth; (Journal of American Physicians and Surgeons, Volt 8, #2, 2003). Calhoun and Rooney comment on 4 important studies dating from 1993 to 1999. The Lumley studies […]
2003 Calhoun-Rooney Read More Ā»
Holland, MichiganāToday the American Association of Pro-Life Obstetricians and Gynecologists (AAPLOG), together with the Christian Medical Association and Concerned Women for America, filed a response with the FDA to claims of the Population Council, Inc., and Danco Laboratories, LLC. The Population Council holds the U.S. patent on mifepristone and Danco Laboratories distributes mifepristone in the
THE THORP LITERATURE REVIEW, 2002 Reference: Thorp, et. al., Long term Physical and Psychological Health Consequences of Induced Abortion: Review of the Evidence; (OB GYN Survey, Vol 58 #l, 2002). 6 studies, totaling 10,790 patients, show no association between spontaneous abortion (āmiscarriageā) and subsequent preterm birth. 12 studies, totaling 34,929 patients, showed no association between
AAPLOG Files Citizen Petition on Mifepristone (Mifeprex) with FDA Holland, MichiganāThe American Association of Pro-Life Obstetricians and Gynecologists, together with the Christian Medical Association and Concerned Women for America, filed a response on August 20 with the Food & Drug Administration requesting immediate revocation of the approval of Mifeprex (RU-486), the abortion pill. The petition
AAPLOG Files Citizen Petition on Mifepristone (Mifeprex) with FDA Read More Ā»
May 23, 2002 Ralph Hale, M.D. Executive Vice President The American College of Obstetricians and Gynecologists 409 12th Street, S.W. Washington, D.C. 20090-6920 Dear Dr. Hale: We write to object to your prior efforts, purportedly on behalf of the American College of Obstetricians and Gynecologists, to compromise the FDAās proposed restrictions on the use of
Letter to ACOG Regarding Mifepristone (Mifeprex) Advocacy Read More Ā»
The membership of the American Association of Pro-Life Obstetricians and Gynecologists (AAPLOG) considers it unethical to attempt the cloning of human beings, or to create human embryos via cloning, for any purpose. We believe that a new human life normally begins at conception with the union of an egg from a women and a sperm
THE AMERICAN ASSOCIATION OF PRO LIFE OBSTETRICIANS AND GYNECOLOGISTS Dr. Charles B. Hammond President, ACOG May 2001 Dear Dr. Hammond and ACOG Officers, We would like to express our congratulations to you, Dr. Hammond, as the new president of ACOG. We are aware of, and respect, your reputation as a physician, scientist and educator. We
Letter to incoming ACOG President Hammond Read More Ā»
The association of induced abortion and the subsequent development of breast cancer. Letter to incoming ACOG President Hammond Letter in 2001, urging academically balanced examination of the evidence for an association between induced abortion and subsequent development of breast cancer.ā¦
On September 28, 2000 the United States Food and Drug Administration (FDA) announced the approval of mifepristone, in combination with misoprostol, for early pregnancy termination.1 This decision received the unqualified approval of the American College of Obstetricians and Gynecologists (ACOG). Mifepristone is also known as RU 486 and is marketed in the United States under
AAPLOG Statement on FDA Approval of Mifeprex (RU 486) Read More Ā»
AAPLOG Response to ACOG Executive Board Statement of Policy Re: āPartial Birth Abortion,ā dated 12 Jan 97. The American Association of ProLife Obstetricians and Gynecologists Feb 1997 Fredric D. Frigoletto, Jr., M.D., President Executive Board American College of Obstetricians and Gynecologists 409 12th Street, SW P.O. Box 96920 Washington, D.C. 20090-6920 Dear Dr. Frigoletto, We
AAPLOG letter to ACOG, detailing our objections to the ACOG policy Read More Ā»